We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – News and Features

News

Warnex to Perform Pharmacogenetic Services for Schering-Plough Canada

Warnex’s Medical Laboratories division will develop pharmacogenetic assays and serve as a central laboratory for several clinical studies of Schering-Plough Canada.
News

Combination of Introgen’s Nanoparticles Show Increased Efficacy in the Treatment of Metastatic Lung Cancer

Two powerful tumor suppressor genes, p53 and FUS1, administered intravenously in nanoparticle formulations are capable of shrinking metastatic tumors in models of human lung cancer.
News

Osiris Recieves FDA Fast Track status and Clearance to Start Phase III trials for Crohn’s Disease Stem Cell Therapy

Company’s Phase III program will be the last phase of testing before it seeks full approval for Crohn’s Disease.
News

Caliper Life Sciences Launches Drug Discovery and Development Services Business

Caliper combines in vitro and in vivo services of Novascreen Biosciences and Xenogen Biosciences to form Discovery Alliances & Services.
News

New Report Finds Little Evidence to Determine the Usefulness of Genetic Tests in the Treatment of Depression

This evidence report is the first step in the two-step process of the Centers for Disease Control and Prevention's Evaluation of Genomic Applications in Practice and Prevention pilot project.
News

Iongate Leads Collaboration to Develop Tools to Predict and Evaluate Undesirable Side Effects in Pharmaceuticals

The project lead by Iongate involves quantitative analysis that can facilitate the description of dynamic processes in living systems.
News

Launch of New Center for Proteomics and Drug Actions

Vanderbilt University Medical Center and the National Foundation for Cancer Research have established a cancer research center from $1 million funded by NFCR.
News

Key Immune Cells Predict Recurrence in Lung Cancer Patients

Researchers found that the more T-regulatory cells and the fewer T-cell lymphocytes present in the tumors of treated patients, the greater the likelihood the cancer would recur.
News

Genedata Expands High Content Screening Collaboration with Serono

Serono will use Genedata’s computational solution to combine results from HCS assays with chemical and pharmacological information to identify promising drug candidates.
News

NIH Selects Purdue to use phi29 DNA Packaging Motor for National Nanomedicine Development Center

A multidisciplinary Purdue research team will lead one of eight national nanomedicine development centers.
Advertisement